| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Gabapentin 300mg capsule and 600mg tablet titration pack (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely glucosamine 500 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Miglustat 100 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Acetaminophen 325 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Acetaminophen 80 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely paracetamol 160 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Ibuprofen 200 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely kanamycin sulfate 500 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely ceftibuten 400 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Cloxacillin sodium 250 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely cloxacillin sodium 500 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely dicloxacillin sodium 125 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Tolterodine L-tartrate 4mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Clindamycin hcl 300mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely lincomycin hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Erythromycin 250mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Erythromycin estolate 250 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Troleandomycin 250 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Phendimetrazine tartrate 105mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Phentermine hydrochloride 30mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pentobarbital sodium 100 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely novobiocin sodium 250 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Acetaminophen 325 mg and butalbital 50 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely calcium acetate 667 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Calcium acetate 333.5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely chlordiazepoxide hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Tetracycline 100 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Temazepam 7.5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Carbamazepine 300mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Carbamazepine 200mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely oxytetracycline hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely nitrofurantoin 25 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely flucytosine 250 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Flucytosine 500 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Griseofulvin 250 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Quinine sulfate 325 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Quinine sulfate 200 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Fexofenadine hydrochloride 60 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Divalproex sodium 125mg capsule sprinkle (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Methyltestosterone 10 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely methoxsalen 10 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Hydrochlorothiazide 12.5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Benzonatate 100 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Nitroglycerin 2.5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Nitroglycerin 6.5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely glyceryl trinitrate 9 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely ergocalciferol 50000 unit/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Benzonatate 200 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely phenylpropanolamine 75 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Cobalt chloride, co-57 0.012 ml/1 each oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Cinoxacin 250 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely cinoxacin 500 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Loracarbef 200 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Loracarbef 400 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely succimer 100 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely ergocalciferol 1.25 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Ziprasidone (as ziprasidone hydrochloride) 20 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely ziprasidone hydrochloride 40 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely ziprasidone (as ziprasidone hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely ziprasidone hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Dronabinol 2.5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Dronabinol 5 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely dronabinol 10 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely calcifediol 20 microgram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Dofetilide 500 microgram oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely mesuximide 150 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Cefdinir 300 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 94.3mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 210.33mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 346.86mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 312.17mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 184.84mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 4500unit capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 183.49mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 278.72% capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Thalidomide 50 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Pancrelipase, amylase:lipase 62.81% capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Methsuximide 300 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Progesterone 200 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely hydroxyzine pamoate 50 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely hydroxyzine pamoate 100 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Encainide hydrochloride 25 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely imipramine pamoate 125 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Imipramine pamoate 150 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely tolmetin sodium 400 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Amoxicillin trihydrate 250mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Amoxicillin trihydrate 500mg capsule (product) | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  | 
| Imipramine pamoate 75 mg oral capsule | a une forme pharmaceutique (attribut) | False | Capsule | Inferred relationship | Some |  |